Ophthalmology · Daytona Beach, FL
NPI
1598902579
Since 2009
Specialty
Ophthalmology
Code 207W00000X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
529 Health Blvd
Daytona Beach, FL, 32114
Phone (800) 255-7188
Groups this clinician bills Medicare through
Medicare paid, 2024
$4.3M
53,694 services
Medicare patients, 2024
1,237
Average age 78
Drug cost, 2024
$1.2M
980 prescriptions
Company payments, 2025
$1,563
From 7 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Karl E Waite was code J2777 (injection, faricimab-svoa, 0.1 mg), 29,948 times for 93 patients. In total Karl E Waite billed 53,694 services in 39 codes, and Medicare paid $4.3M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-10-28.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J2777 Injection, faricimab-svoa, 0.1 mg | Office | 29,948 | 93 | $27.59 | $826K |
| 92202 Ophthalmological E&M | Office | 4,101 | 1,229 | $10.74 | $44K |
| 92134 Computerized Ophthalmic Imaging | Office | 3,576 | 1,182 | $27.84 | $100K |
| 92012 Ophthalmological E&M | Office | 3,454 | 1,047 | $60.45 | $209K |
| J0178 Injection, aflibercept, 1 mg | Office | 2,788 | 309 | $661.01 | $1.8M |
| 67028 Intravitreal Injection | Office | 2,428 | 462 | $81.56 | $198K |
| J0177 Injection, aflibercept hd, 1 mg | Office | 2,428 | 124 | $262.89 | $638K |
| J3490 Unclassified drugs | Office | 2,079 | 46 | $72.59 | $151K |
| J2782 Injection, avacincaptad pegol, 0.1 mg | Office | 1,660 | 23 | $86.63 | $144K |
| 92014 Ophthalmological E&M | Office | 410 | 372 | $83.09 | $34K |
| J7312 Injection, dexamethasone, intravitreal implant, 0.1 mg | Office | 231 | 11 | $153.30 | $35K |
| 99204 Office E&M - New | Office | 219 | 219 | $120.16 | $26K |
| 92235 Angiography | Office | 110 | 110 | $119.10 | $13K |
| J7999 Compounded drug, not otherwise classified | Office | 39 | 18 | $66.64 | $2,599 |
| 67145 Eye | Office | 31 | 30 | $174.35 | $5,405 |
By year: 2022 $4.2M for 24,076 services; 2023 $3.9M for 46,587 services; 2024 $4.3M for 53,694 services.
Medicare prescription drug claims, 2024
In 2024, the drug Karl E Waite prescribed most often to Medicare patients was Prednisolone Acetate, with 189 prescriptions and refills. In total Karl E Waite wrote 980 Medicare prescriptions that cost $1.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prednisolone Acetate Generic | 189 | 275 | 136 | $5,382 |
| Eylea Aflibercept | 179 | 265 | 52 | $455K |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 149 | 366 | 76 | $2,312 |
| Vabysmo Faricimab-Svoa | 146 | 192 | 32 | $423K |
| Brimonidine Tartrate Generic | 53 | 75 | 18 | $1,514 |
| Izervay Avacincaptad Pegol Sodium/Pf | 49 | 87 | 12 | $145K |
| Difluprednate Generic | 47 | 70 | 23 | $4,369 |
| Eylea Hd Aflibercept | 28 | 35 | Under 11 | $74K |
| Latanoprost Generic | 24 | 46 | Under 11 | $279 |
| Ozurdex Dexamethasone | 18 | 48 | 11 | $38K |
| Loteprednol Etabonate Generic | 17 | 25 | Under 11 | $1,254 |
| Atropine Sulfate Generic | 16 | 41 | 16 | $482 |
| Moxifloxacin Moxifloxacin Hcl | 12 | 12 | Under 11 | $247 |
Brand drugs: 671 claims; generic drugs: 309 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Karl E Waite $1,563 ($1,563 in general payments such as food, travel and fees) from 7 companies. The largest payer was Astellas Pharma US Inc with $437.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.